Benitec Biopharma Inc.
BNTCBiotechnology
$8.74−1.02%As of Oct 30vs prior close
- Market cap
- $304.9M
- P/E (TTM)
- –
- From 52W high
- −46.58%
- EPS (LTM)
- -$0.82
- Revenue (YE24)
- $0
- Dividend yield
- 0.00%
Nomior Score
35
Steady ProfileBottom 21% of the scored universe
Growth—
Quality53
Value50
Momentum8
Resilience47
Growth
$0revenue, YE24
YE19 $12.2MYE24 $0
Connections
Revenue to profitYE23
The operating loss was 25441% of revenue, wider by 984 pts on a year.
Who owns it
2funds